Regenstrief Institute research scientist Noll Campbell, PharmD, MS recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline.
Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., led a discussion as part of a Learning Health System Leaders Webinar Series put on by the Northwest Learning Health Systems Center of Excellence and K12.
©2020 Regenstrief Institute, Inc. All rights reserved.
1101 West Tenth Street • Indianapolis, IN 46202
